Notably, the expression of MUC4 can be detected in the plasma and is correlated well with the relative expression of MUC4 in paraffin-embedded specimens in CCA patients, providing the feasibility for prompt clinical monitoring of GEM response. Here, MUC4 is linked to cholangiocarcinoma.